These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 15519762)

  • 1. Glycolic acid and D-lactate-putative products of DJ-1-restore neurodegeneration in FUS - and SOD1-ALS.
    Pal A; Grossmann D; Glaß H; Zimyanin V; Günther R; Catinozzi M; Boeckers TM; Sterneckert J; Storkebaum E; Petri S; Wegner F; Grill SW; Pan-Montojo F; Hermann A
    Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38760174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review.
    Ramasubbu K; Devi Rajeswari V
    Mol Cell Biochem; 2023 Jun; 478(6):1307-1324. PubMed ID: 36308670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases.
    Cepas V; Collino M; Mayo JC; Sainz RM
    Antioxidants (Basel); 2020 Feb; 9(2):. PubMed ID: 32041293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis.
    Allen SP; Hall B; Woof R; Francis L; Gatto N; Shaw AC; Myszczynska M; Hemingway J; Coldicott I; Willcock A; Job L; Hughes RM; Boschian C; Bayatti N; Heath PR; Bandmann O; Mortiboys H; Ferraiuolo L; Shaw PJ
    Brain; 2019 Dec; 142(12):3771-3790. PubMed ID: 31647549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GlyStruct: glycation prediction using structural properties of amino acid residues.
    Reddy HM; Sharma A; Dehzangi A; Shigemizu D; Chandra AA; Tsunoda T
    BMC Bioinformatics; 2019 Feb; 19(Suppl 13):547. PubMed ID: 30717650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration.
    Derk J; MacLean M; Juranek J; Schmidt AM
    J Alzheimers Dis Parkinsonism; 2018; 8(1):. PubMed ID: 30560011
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components.
    Sadowska-Bartosz I; Galiniak S; Bartosz G
    Molecules; 2014 Nov; 19(11):18828-49. PubMed ID: 25407721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
    Salahuddin P; Rabbani G; Khan RH
    Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds.
    Sadowska-Bartosz I; Galiniak S; Bartosz G
    Molecules; 2014 Apr; 19(4):4880-96. PubMed ID: 24747646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of methylglyoxal in Alzheimer's disease.
    Angeloni C; Zambonin L; Hrelia S
    Biomed Res Int; 2014; 2014():238485. PubMed ID: 24734229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.
    Zhang Q; Monroe ME; Schepmoes AA; Clauss TR; Gritsenko MA; Meng D; Petyuk VA; Smith RD; Metz TO
    J Proteome Res; 2011 Jul; 10(7):3076-88. PubMed ID: 21612289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.
    Pradat PF; Dib M
    Mol Diagn Ther; 2009; 13(2):115-25. PubMed ID: 19537846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress biomarkers in sporadic ALS.
    Mitsumoto H; Santella RM; Liu X; Bogdanov M; Zipprich J; Wu HC; Mahata J; Kilty M; Bednarz K; Bell D; Gordon PH; Hornig M; Mehrazin M; Naini A; Flint Beal M; Factor-Litvak P
    Amyotroph Lateral Scler; 2008 Jun; 9(3):177-83. PubMed ID: 18574762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H
    Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord.
    Kikuchi S; Shinpo K; Ogata A; Tsuji S; Takeuchi M; Makita Z; Tashiro K
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):63-8. PubMed ID: 12215227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and cerebrospinal fluid biochemical markers of ALS.
    Shaw PJ; Williams R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1 Suppl 2():S61-7. PubMed ID: 11464944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.